RDA Financial Network Purchases 102 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

RDA Financial Network grew its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.2% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 8,269 shares of the medical equipment provider’s stock after purchasing an additional 102 shares during the period. Intuitive Surgical comprises about 1.3% of RDA Financial Network’s portfolio, making the stock its 15th largest position. RDA Financial Network’s holdings in Intuitive Surgical were worth $4,062,000 at the end of the most recent reporting period.

A number of other large investors also recently made changes to their positions in the company. Capital Research Global Investors bought a new position in Intuitive Surgical during the first quarter valued at about $374,390,000. Vanguard Group Inc. grew its position in shares of Intuitive Surgical by 1.6% during the 1st quarter. Vanguard Group Inc. now owns 30,868,620 shares of the medical equipment provider’s stock valued at $12,319,358,000 after acquiring an additional 493,126 shares during the period. BNP PARIBAS ASSET MANAGEMENT Holding S.A. increased its stake in shares of Intuitive Surgical by 51.2% during the 1st quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 893,341 shares of the medical equipment provider’s stock worth $356,524,000 after purchasing an additional 302,382 shares during the last quarter. Strategic Financial Concepts LLC raised its holdings in shares of Intuitive Surgical by 40,221.4% in the 2nd quarter. Strategic Financial Concepts LLC now owns 266,121 shares of the medical equipment provider’s stock worth $1,184,000 after purchasing an additional 265,461 shares during the period. Finally, GQG Partners LLC purchased a new position in Intuitive Surgical in the first quarter valued at approximately $99,523,000. 83.64% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

ISRG has been the subject of a number of recent research reports. JPMorgan Chase & Co. raised their target price on Intuitive Surgical from $495.00 to $575.00 and gave the stock an “overweight” rating in a research report on Friday. Royal Bank of Canada boosted their price objective on Intuitive Surgical from $515.00 to $525.00 and gave the company an “outperform” rating in a research note on Tuesday, October 8th. BTIG Research increased their target price on shares of Intuitive Surgical from $494.00 to $518.00 and gave the stock a “buy” rating in a research report on Monday. Truist Financial boosted their price target on shares of Intuitive Surgical from $520.00 to $570.00 and gave the company a “buy” rating in a research report on Monday. Finally, Morgan Stanley lifted their price objective on shares of Intuitive Surgical from $375.00 to $460.00 and gave the company an “equal weight” rating in a research note on Monday, July 15th. Six investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $467.55.

Intuitive Surgical Price Performance

ISRG stock traded down $9.62 during mid-day trading on Tuesday, hitting $477.99. 764,053 shares of the stock were exchanged, compared to its average volume of 1,462,655. The business has a fifty day moving average price of $481.33 and a 200 day moving average price of $435.81. Intuitive Surgical, Inc. has a 12 month low of $254.85 and a 12 month high of $496.48. The stock has a market capitalization of $169.54 billion, a price-to-earnings ratio of 88.02, a PEG ratio of 5.40 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, July 18th. The medical equipment provider reported $1.78 earnings per share for the quarter, topping analysts’ consensus estimates of $1.54 by $0.24. Intuitive Surgical had a return on equity of 13.04% and a net margin of 27.65%. The company had revenue of $2.01 billion during the quarter, compared to the consensus estimate of $1.97 billion. During the same quarter in the previous year, the company posted $1.18 EPS. Intuitive Surgical’s quarterly revenue was up 14.5% compared to the same quarter last year. As a group, equities analysts forecast that Intuitive Surgical, Inc. will post 5.22 EPS for the current fiscal year.

Insider Activity

In other news, EVP Robert Desantis sold 188 shares of the firm’s stock in a transaction dated Thursday, August 29th. The stock was sold at an average price of $482.21, for a total transaction of $90,655.48. Following the transaction, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at approximately $2,655,048.26. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other news, EVP Robert Desantis sold 188 shares of the firm’s stock in a transaction that occurred on Thursday, August 29th. The shares were sold at an average price of $482.21, for a total value of $90,655.48. Following the transaction, the executive vice president now owns 5,506 shares in the company, valued at approximately $2,655,048.26. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Myriam Curet sold 2,818 shares of the company’s stock in a transaction on Tuesday, July 23rd. The shares were sold at an average price of $458.13, for a total transaction of $1,291,010.34. Following the sale, the executive vice president now owns 298 shares of the company’s stock, valued at $136,522.74. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 53,120 shares of company stock valued at $25,528,753. Corporate insiders own 0.90% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.